Your browser doesn't support javascript.
loading
A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients.
Sun, Chaoyang; Guo, Ensong; Zhou, Bo; Shan, Wanying; Huang, Jia; Weng, Danhui; Wu, Peng; Wang, Changyu; Wang, Shixuan; Zhang, Wei; Gao, Qinglei; Xu, Xiaoyan; Wang, Beibei; Hu, Junbo; Ma, Ding; Chen, Gang.
Afiliación
  • Sun C; Cancer Biology Research Center (Key laboratory of Chinese Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Guo E; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Zhou B; Cancer Biology Research Center (Key laboratory of Chinese Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Shan W; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Huang J; Cancer Biology Research Center (Key laboratory of Chinese Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Weng D; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Wu P; Cancer Biology Research Center (Key laboratory of Chinese Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Wang C; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Wang S; Cancer Biology Research Center (Key laboratory of Chinese Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Zhang W; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Gao Q; Cancer Biology Research Center (Key laboratory of Chinese Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Xu X; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Wang B; Cancer Biology Research Center (Key laboratory of Chinese Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Hu J; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Ma D; Cancer Biology Research Center (Key laboratory of Chinese Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Chen G; Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
BMC Cancer ; 19(1): 1061, 2019 Nov 08.
Article en En | MEDLINE | ID: mdl-31703584

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proyectos de Investigación / Cisplatino / Especies Reactivas de Oxígeno / Resistencia a Antineoplásicos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Proyectos de Investigación / Cisplatino / Especies Reactivas de Oxígeno / Resistencia a Antineoplásicos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article